RCT Study of Levosimendan Improving Prognosis of Cardiac Arrest

NCT05956431 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Heart Arrest

Interventions

DRUG: Levosimendan Injection
DRUG: physiological saline

Sponsor

Peking University Third Hospital

Collaborators

[object Object]